#VisualAbstract: Perioperative Durvalumab increased Survival in Gastric and Gastroesopha-geal Junction Cancer
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: gastroesophageal junction cancer
#VisualAbstract: First-Line Sugemalimab Plus Chemotherapy Provides Survival Benefit in Advanced Gastric Cancer
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Fruquintinib Plus Paclitaxel Improved Progression-Free Survival in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Click here to read this study in Nature Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
#VisualAbstract: Nivolumab plus chemotherapy improves progression-free survival in gastric or gastroesophageal junction cancer
Click to read this study in The Lancet Oncology.
#VisualAbstract: Neoadjuvant chemotherapy plus surgery improves overall survival compared to surgery alone in locally advanced esophageal cancer
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Positron emission tomography effective at assessing early tumor response to induction chemotherapy in esophageal or esophagogastric junction cancers
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy
Click to read the study in The Lancet Oncology.
#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma
Click to read the study in the European Journal of Cancer.
Adjunctive nivolumab reduces risk of death and progression of gastric adenocarcinoma compared to chemotherapy alone
1. Overall survival and progression-free survival were higher for patients on nivolumab plus chemotherapy compared to chemotherapy alone. 2. Severe ...
